GC
IMI

Guggenheim Capital’s Intermolecular, Inc. IMI Stock Holding History

Guggenheim Capital’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,779
Closed -$11K – 2876
2017
Q3 		$11K Sell
10,779
-27
-0.2% -$25 ﹤0.01% 2777
2017
Q2 		$10K Hold
10,806
– – ﹤0.01% 2811
2017
Q1 		$10K Buy
+10,806
New +$11.3K ﹤0.01% 2818
2014
Q2 		– Sell
-10,870
Closed -$31K – 3343
2014
Q1 		$31K Buy
+10,870
New +$39.6K ﹤0.01% 3191

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Guggenheim Capital's IMI Position: Q4 2017 in Review

Guggenheim Capital sold out of Intermolecular, Inc. (IMI) in Q4 2017, closing a stake of 10,779 shares — an estimated $11K sold.

Guggenheim Capital first reported a position in IMI in Q1 2014 and held it in 4 quarters. The position peaked at $31K in Q1 2014. 24 funds tracked by Wall St. Rank hold IMI as of Q4 2017.

  • Guggenheim Capital reported no remaining Intermolecular, Inc. position as of Q4 2017 after selling out during the quarter.
  • Guggenheim Capital sold 10,779 Intermolecular, Inc. shares in Q4 2017, an estimated $11K.
  • Guggenheim Capital first reported a position in Intermolecular, Inc. in Q1 2014 and held it in 4 quarters.
  • Guggenheim Capital's Intermolecular, Inc. position peaked at $31K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q4 2017.

Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.